Back to User profile » Miss Rayan Dakroub
Paper published by Miss Rayan Dakroub:
Original Research
Therapeutic Advantage of Targeting PRMT5 in Combination with Chemotherapies or EGFR/HER2 Inhibitors in Triple-Negative Breast Cancers
Dakroub R, Huard S, Hajj-Younes Y, Suresh S, Badran B, Fayyad-Kazan H, Dubois T
Breast Cancer: Targets and Therapy 2023, 15:785-799
Published Date: 6 November 2023